[Federal Register Volume 60, Number 11 (Wednesday, January 18, 1995)]
[Notices]
[Pages 3645-3646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-1091]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Ad Hoc Review Committee for the Recombinant DNA Advisory 
Committee; Notice of Meeting

    Notice is given of a meeting of the Ad Hoc Review Committee for the 
Recombinant DNA Advisory Committee on February 3, 1995, at the National 
Institutes of Health, Building 31, 9000 Rockville Pike, Bethesda, 
Maryland 20892. The meeting will be held from approximately 9 a.m. to 
12 noon in Room 2C15, and continue in Room 5A16 from approximately 12 
noon to adjournment at approximately 5 p.m. The meeting will be open to 
the public to discuss three major topics for review: (1) Domain and 
mandate of the Recombinant DNA Advisory Committee; (2) composition of 
the Recombinant DNA Advisory Committee; and (3) Recombinant DNA 
Advisory Committee's review of human gene transfer protocols. Members 
of the public wishing to speak at this meeting may be given such 
opportunity at the discretion of the Chair.
    Dr. Nelson A. Wivel, Director, Office of Recombinant DNA 
Activities, Suite 323, National Institutes of Health, 6006 Executive 
Boulevard, MSC 7052, Bethesda, Maryland 20892-7052, Phone (301) 496-
9838, FAX (301) 496-9839, will provide materials to be discussed at 
this meeting, roster of committee members, and substantive program 
information. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should contact Dr. Wivel in advance of the meeting. A 
summary of the meeting will be available at a later date.

    [[Page 3646]] Dated: January 11, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-1091 Filed 1-17-95; 8:45 am]
BILLING CODE 4140-01-M